Search
Filters
Clear All
  • 37

Phase

  • 2
  • 9
  • 24
  • 36
  • 35

Found 37 sandeep-batra-md trials

A listing of sandeep-batra-md medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

S
Sandeep Batra, MD
1-25 years
All genders
Phase 3
Interventional
This phase III trial studies whether inotuzumab ozogamicin added to post-inductionhemotherapy for patients with High-Risk B-cell Acute Lymphoblastic Leukemia (B-ALL) improvesutcomes. This trial also studies the outcomes of patients with mixed phenotype acuteukemia (MPAL), and B-lymphoblastic lymphoma (B-LLy) when treated with ALL therapy withoutuzumab ozogamicin. Inotuzumab ozogamicin is a monoclonal …
Learn More

A Study to Compare Treatment With the Drug Selumetinib Alone Versus Selumetinib and Vinblastine in Patients With Recurrent or Progressive Low-Grade Glioma

S
Sandeep Batra, MD
2-25 years
All genders
Phase 3
Interventional
This phase III trial investigates the best dose of vinblastine in combination withumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinibg children and young adults with low-grade glioma (a common type of brain) that has come back after prior treatment (recurrent) or does not respond to therapy …
Learn More

NCI-COG Pediatric MATCH (Molecular Analysis for Therapy Choice) Screening Protocol

S
Sandeep Batra, MD
1-21 years
All genders
This screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has …
Learn More

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

S
Sandeep Batra, MD
21 years and younger
All genders
Phase 3
Interventional
This phase III trial compares standard chemotherapy to therapy with liposome-encapsulated daunorubicin-cytarabine (CPX-351) and/or gilteritinib for patients with newly diagnosed acuteyeloid leukemia with or without FLT3 mutations. Drugs used in chemotherapy, such as daunorubicin, cytarabine, and gemtuzumab ozogamicin, work in different ways to stop the growth of cancer cells, either …
Learn More

A COG Soft Tissue Sarcoma Biology and Banking Protocol

S
Sandeep Batra, MD
50-100 years
All genders
The purpose of this study is to better diagnose certain types of cancer.
Learn More

Enasidenib for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Patients With an IDH2 Mutation

S
Sandeep Batra, MD
24-18 years
All genders
Phase 2
Interventional
This trial studies the side effects of enasidenib and to see how well it works in treatingwith acute myeloid leukemia that has come back after treatment (relapsed) or has been difficult to treat with chemotherapy (refractory). Patients must also have a specific genetic change, also called a mutation, in a …
Learn More

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

S
Sandeep Batra, MD
22 years and younger
All genders
Interventional
This study aims to use clinical and biological characteristics of acute leukemias to screengibility for available pediatric leukemia sub-trials. Testing bone marrow and blood from patients with leukemia that has come back after treatment or is difficult to treaty provide information about the patient's leukemia that is important when deciding …
Learn More

A Phase 2 Study of the MEK Inhibitor Trametinib in Children With Relapsed or Refractory Juvenile Myelomonocytic Leukemia

S
Sandeep Batra, MD
21 years and younger
All genders
This phase II trial studies how well trametinib works in treating patients with juvenile myelomonocytic leukemia that has come back or does not respond to treatment.
Learn More

A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients With Low-Grade Glioma

S
Sandeep Batra, MD
2-21 years
All genders
Phase 3
Interventional
This phase III trial compares the effect of selumetinib versus the standard of care treatment with carboplatin and vincristine (CV) in treating patients with newly diagnosed or previously untreated low-grade glioma (LGG) that does not have a genetic abnormality called BRAFV600Eutation and is not associated with systemic neurofibromatosis type 1. …
Learn More

Pediatric Hepatic Malignancy International Therapeutic Trial (PHITT)

S
Sandeep Batra, MD
30 years and younger
All genders
This trial studies how well cisplatin and combination chemotherapy works in treating children and young adults with hepatoblastoma or liver cancer after surgery.
Learn More
11 - 20 of 37